GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beamtree Holdings Ltd (ASX:BMT) » Definitions » Research & Development

Beamtree Holdings (ASX:BMT) Research & Development : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Beamtree Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Beamtree Holdings's Research & Development for the six months ended in Dec. 2023 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Beamtree Holdings Research & Development Historical Data

The historical data trend for Beamtree Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beamtree Holdings Research & Development Chart

Beamtree Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Research & Development
- - - -

Beamtree Holdings Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Beamtree Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beamtree Holdings  (ASX:BMT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Beamtree Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Beamtree Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Beamtree Holdings (ASX:BMT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beamtree Holdings Ltd (ASX:BMT) » Definitions » Research & Development
Comparable Companies
ASX:PCK ASX:IME ASX:RHT ASX:PHX ASX:EMD ASX:MDR ASX:AYA ASX:1STDA ASX:GLH ASX:CTQ VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH
Traded in Other Exchanges
N/A
Address
16 Eveleigh Street, Level 1, Redfern, NSW, AUS, 2016
Website
https://www.beamtree.com.au
Beamtree Holdings Ltd is engaged in the development of an integrated platform for information and knowledge management, empowering a learning health system. Beamtree, incorporating AI and ML is providing end-to-end support from the moment of data collection and classification through quality and performance benchmarking to clinical decision support at point of care.

Beamtree Holdings (ASX:BMT) Headlines

No Headlines